Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-02-25
Original SEC Filing: Click here

---

Webplus: BSPM/20100225/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Provides Preliminary 2009 Results: Revenue of $52 – $54 Million and Operatingome of $16 $17 million excluding non-cash charges XIANYANG, China, February 25, 2010 (Xinhua-PRNewswire-FirstCall) Biostar expects to report gross margin for 2009 of approximately 71%, anrease of 1200 basis-pointsmpared to 59% in 2008. Management anticipates unaudited operatingome, excluding non-cash charges, of approximately

---

---

Webplus: BSPM/20100225/8-K/1/000.htm SEC Original: biostar8k022510.htm
FORM 8-K CURRENT REPORT February 25, 2010te of report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 333-147363 20-5101287 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 (Issuer Telephone Number)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-02-25CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046